RHYTHM PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.19% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-26
- RHYTHM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.19%.
- RHYTHM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -1.61%.
- RHYTHM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.16%.
- RHYTHM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.02%, a 104.26% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.19% 10-K · filed 2026-02-26 | |
| 2024-12-31 | -1.61% 10-K · filed 2026-02-26 | |
| 2023-12-31 | -0.16% 10-K · filed 2026-02-26 | 0.48% 10-K · filed 2024-02-29 |
| 2022-12-31 | -0.02% 10-K · filed 2025-02-28 | 0.04% 10-K · filed 2023-03-01 |
| 2021-12-31 | 0.47% 10-K · filed 2024-02-29 | |
| 2020-12-31 | 0.30% 10-K · filed 2023-03-01 | |
| 2019-12-31 | -0.20% 10-K · filed 2022-03-01 | |
| 2018-12-31 | -0.05% 10-K · filed 2021-03-01 | |
| 2017-12-31 | 0.07% 10-K · filed 2020-03-02 | |
| 2016-12-31 | 1.32% 10-K · filed 2019-03-08 | |
| 2015-12-31 | 2.23% 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |